Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07295340

Diagnostic Accuracy of Folate-Targeted NIR-II Carbon Dots for Ex Vivo HCC Detection

Application of Folic Acid-Targeted Near-Infrared-II (NIR-II) Carbon Dots in Ex Vivo Histopathological Analysis of Hepatocellular Carcinoma

Status
Recruiting
Phase
Study type
Observational
Enrollment
20 (estimated)
Sponsor
West China Hospital · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This prospective, single-center observational study evaluates the diagnostic accuracy of a novel Folate-targeted Near-Infrared II Carbon Dot (FA-CDots) probe for the ex vivo assessment of Hepatocellular Carcinoma (HCC). Following standard radical hepatectomy, resected liver specimens will be incubated with the FA-CDots probe and imaged using a NIR-II fluorescence system. The study aims to determine the feasibility and accuracy of this technology in identifying tumor margins and micro-lesions by comparing the fluorescence imaging results with standard histopathological examination.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTEx Vivo FA-CDots StainingThe resected liver specimens are incubated with Folate-targeted Near-Infrared II Carbon Dots (FA-CDots) and imaged using a NIR-II fluorescence imaging system to identify tumor margins and micro-lesions. The results are compared with standard histopathology.

Timeline

Start date
2026-01-01
Primary completion
2027-04-01
Completion
2027-10-01
First posted
2025-12-19
Last updated
2025-12-19

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07295340. Inclusion in this directory is not an endorsement.